Page 93 - Read Online

Page 4 of 5 Muttin et al. Mini-invasive Surg 2019;3:10 I http://dx.doi.org/10.20517/2574-1225.2018.005

CONCLUSION
An accurate diagnosis of SRM can be made by using RTB and will further improve the risk-stratification of
patients and guide the treatment strategy. Moreover, AS is a viable alternative to standard PN for SRM and
should be discussed with candidates for active intervention, according to the baseline health status and the
characteristics of the tumor provided by the RTB.

DECLARATIONS
Authors’ contributions
Data analysis and interpretation, manuscript writing and editing: Muttin F
Conception and design of the study, supervision and critical revision for important intellectual content:
Barret E

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable

Copyright
© The Author(s) 2019.

REFERENCES
1. Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, et al. European association of urology guidelines on renal cell
carcinoma: the 2019 update. Eur Urol 2019; doi:10.1016/j.eururo.2019.02.011.
2. Richard PO, Jewett MAS, Bhatt JR, Kachura JR, Evans AJ, et al. Renal tumor biopsy for small renal masses: a single-center 13-year
experience. Eur Urol 2015;68:1007-13.
3. Marconi L, Dabestani S, Lam TB, Hofmann F, Stewart F, et al. Systematic review and meta-analysis of diagnostic accuracy of
percutaneous renal tumour biopsy. Eur Urol 2016;69:660-73.
4. Herrera-Caceres JO, Finelli A, Jewett MAS. Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment
decision management. World J Urol 2018;362:624.
5. Patel HD, Johnson MH, Pierorazio PM, Sozio SM, Sharma R, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal
mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol 2016;195:1340-7.
6. Richard PO, Jewett MAS, Tanguay S, Saarela O, Liu ZA, et al. Safety, reliability and accuracy of small renal tumour biopsies: results
from a multi-institution registry. BJU Int 2017;119:543-9.
7. Mir MC, Capitanio U, Bertolo R, Ouzaid IP, Salagierski M, et al. Role of active surveillance for localized small renal masses. Eur Urol
Oncol 2018;1:177-87.
8. Rahbar H, Bhayani S, Stifelman M, Kaouk J, Allaf M, et al. Evaluation of renal mass biopsy risk stratification algorithm for robotic
partial nephrectomy--could a biopsy have guided management? J Urol 2014;192:1337-42.
9. Jewett MAS, Mattar K, Basiuk J, Morash CG, Pautler SE, et al. Active surveillance of small renal masses: progression patterns of early
stage kidney cancer. Eur Urol 2011;60:39-44.
10. Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, et al. Five-year analysis of a multi-institutional prospective clinical trial
of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol 2015;68:408-15.
11. Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, et al. Small renal masses progressing to metastases under active
surveillance: a systematic review and pooled analysis. Cancer 2012;118:997-1006.